O	O	O	0	7	Limited	Limit	B-NP	VBN	O	2	NMOD	O
O	O	O	8	19	proteolysis	proteolysis	I-NP	NN	O	0	ROOT	O
O	O	O	20	23	for	for	B-PP	IN	O	2	NMOD	O
O	O	O	24	32	assaying	assay	B-VP	VBG	O	3	PMOD	O
O	O	O	33	39	ligand	ligand	B-NP	NN	O	7	NMOD	O
O	O	O	40	47	binding	binding	I-NP	NN	O	7	NMOD	O
O	O	O	48	58	affinities	affinity	I-NP	NNS	O	4	OBJ	O
O	O	O	59	61	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	62	69	nuclear	nuclear	B-NP	JJ	B-protein	10	NMOD	B-protein
O	O	O	70	79	receptors	receptor	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	O	79	80	.	.	O	.	O	2	P	O

O	O	O	82	85	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	86	93	binding	binding	I-NP	NN	O	11	SUB	O
O	O	O	94	96	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	97	104	natural	natural	B-NP	JJ	O	7	NMOD	O
O	O	O	105	107	or	or	I-NP	CC	O	7	NMOD	O
O	O	O	108	117	synthetic	synthetic	I-NP	JJ	O	7	NMOD	O
O	O	O	118	125	ligands	ligand	I-NP	NNS	O	3	PMOD	O
O	O	O	126	128	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	129	136	nuclear	nuclear	B-NP	JJ	B-protein	10	NMOD	B-protein
O	O	O	137	146	receptors	receptor	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	O	147	149	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	150	153	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	154	164	triggering	trigger	I-NP	VBG	O	14	NMOD	O
O	O	O	165	170	event	event	I-NP	NN	O	11	PRD	O
O	O	O	171	178	leading	lead	B-VP	VBG	O	14	NMOD	O
O	O	O	179	181	to	to	B-PP	TO	O	15	VMOD	O
O	O	O	182	186	gene	gene	B-NP	NN	O	19	NMOD	O
O	O	O	187	200	transcription	transcription	I-NP	NN	O	19	NMOD	O
O	O	O	201	211	activation	activation	I-NP	NN	O	21	NMOD	O
O	O	O	212	214	or	or	O	CC	O	21	NMOD	O
O	O	O	215	225	repression	repression	B-NP	NN	O	16	PMOD	O
O	O	O	225	226	.	.	O	.	O	11	P	O

O	O	O	227	233	Ligand	Ligand	B-NP	NN	O	11	SUB	O
O	O	O	234	241	binding	binding	I-NP	NN	O	1	NMOD	O
O	O	O	242	244	to	to	B-PP	TO	O	2	VMOD	O
O	O	O	245	248	the	the	B-NP	DT	O	7	NMOD	O
T4	B-Entity	B-Entity	249	255	ligand	ligand	I-NP	NN	B-protein	7	NMOD	B-protein
T4	I-Entity	I-Entity	256	263	binding	binding	I-NP	NN	I-protein	7	NMOD	I-protein
T4	I-Entity	I-Entity	264	270	domain	domain	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	271	273	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	274	279	these	these	B-NP	DT	O	10	NMOD	O
O	O	O	280	289	receptors	receptor	I-NP	NNS	O	8	PMOD	O
O	O	O	290	297	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	O	298	312	conformational	conformational	B-NP	JJ	O	13	NMOD	O
O	O	O	313	320	changes	change	I-NP	NNS	O	11	OBJ	O
O	O	O	321	325	that	that	B-NP	WDT	O	13	NMOD	O
O	O	O	326	329	are	be	B-VP	VBP	O	14	SBAR	O
O	O	O	330	339	evidenced	evidence	I-VP	VBN	O	15	VC	O
O	O	O	340	342	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	343	345	an	an	B-NP	DT	O	20	NMOD	O
O	O	O	346	355	increased	increase	I-NP	VBN	O	20	NMOD	O
O	O	O	356	366	resistance	resistance	I-NP	NN	O	17	PMOD	O
O	O	O	367	369	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	370	374	this	this	B-NP	DT	O	23	NMOD	O
O	O	O	375	381	domain	domain	I-NP	NN	O	21	PMOD	O
O	O	O	382	384	to	to	B-PP	TO	O	20	NMOD	O
O	O	O	385	394	proteases	protease	B-NP	NNS	B-protein	24	PMOD	B-protein
O	O	O	394	395	.	.	O	.	O	11	P	O

O	O	O	396	398	In	In	B-ADVP	FW	O	4	NMOD	O
O	O	O	399	404	vitro	vitro	I-ADVP	FW	O	4	NMOD	O
O	O	O	405	412	labeled	label	B-NP	VBN	O	4	NMOD	O
O	O	O	413	422	receptors	receptor	I-NP	NNS	O	5	SUB	O
O	O	O	423	427	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	428	437	incubated	incubate	I-VP	VBN	O	5	VC	O
O	O	O	438	442	with	with	B-PP	IN	O	6	VMOD	O
O	O	O	443	450	various	various	B-NP	JJ	O	7	PMOD	O
O	O	O	451	460	synthetic	synthetic	I-NP	JJ	O	8	NMOD	O
O	O	O	461	463	or	or	I-NP	CC	O	8	NMOD	O
O	O	O	464	471	natural	natural	I-NP	JJ	O	8	NMOD	O
O	O	O	472	480	agonists	agonist	I-NP	NNS	O	14	NMOD	O
O	O	O	481	483	or	or	I-NP	CC	O	14	NMOD	O
O	O	O	484	495	antagonists	antagonist	I-NP	NNS	O	8	NMOD	O
O	O	O	496	499	and	and	O	CC	O	6	VMOD	O
O	O	O	500	509	submitted	submit	B-VP	VBN	O	6	VMOD	O
O	O	O	510	512	to	to	B-PP	TO	O	16	VMOD	O
O	O	O	513	520	trypsin	trypsin	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	O	521	530	digestion	digestion	I-NP	NN	O	17	PMOD	O
O	O	O	530	531	.	.	O	.	O	5	P	O

O	O	O	532	543	Proteolysis	Proteolysis	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	544	552	products	product	I-NP	NNS	I-protein	3	SUB	I-protein
O	O	O	553	557	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	558	567	separated	separate	I-VP	VBN	O	3	VC	O
O	O	O	568	570	by	by	B-PP	IN	O	4	VMOD	O
O	O	O	571	574	SDS	SDS	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	574	575	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	O	575	579	PAGE	PAGE	I-NP	NN	O	5	PMOD	O
O	O	O	580	583	and	and	O	CC	O	4	VMOD	O
O	O	O	584	594	quantified	quantify	B-VP	VBN	O	4	VMOD	O
O	O	O	594	595	.	.	O	.	O	3	P	O

O	O	O	596	599	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	600	606	amount	amount	I-NP	NN	O	8	SUB	O
O	O	O	607	609	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	610	617	trypsin	trypsin	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	617	618	-	-	B-NP	HYPH	O	7	NMOD	O
O	O	O	618	627	resistant	resistant	I-NP	JJ	O	7	NMOD	O
O	O	O	628	637	fragments	fragment	I-NP	NNS	O	3	PMOD	O
O	O	O	638	641	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	642	654	proportional	proportional	B-ADJP	JJ	O	8	PRD	O
O	O	O	655	657	to	to	B-PP	TO	O	9	AMOD	O
O	O	O	658	666	receptor	receptor	B-NP	NN	O	12	NMOD	O
O	O	O	667	676	occupancy	occupancy	I-NP	NN	O	10	PMOD	O
O	O	O	677	679	by	by	B-PP	IN	O	12	NMOD	O
O	O	O	680	683	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	684	690	ligand	ligand	I-NP	NN	O	13	PMOD	O
O	O	O	690	691	,	,	O	,	O	8	P	O
O	O	O	692	695	and	and	O	CC	O	8	VMOD	O
O	O	O	696	703	allowed	allow	B-VP	VBD	O	8	VMOD	O
O	O	O	704	707	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	708	721	determination	determination	I-NP	NN	O	18	OBJ	O
O	O	O	722	724	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	725	737	dissociation	dissociation	B-NP	NN	O	23	NMOD	O
O	O	O	738	747	constants	constant	I-NP	NNS	O	21	PMOD	O
O	O	O	748	749	(	(	O	(	O	26	DEP	O
O	O	O	749	752	kDa	kDa	B-NP	NN	O	26	DEP	O
O	O	O	752	753	)	)	O	)	O	23	NMOD	O
O	O	O	753	754	.	.	O	.	O	8	P	O

O	O	O	755	760	Using	Use	B-VP	VBG	O	28	VMOD	O
O	O	O	761	764	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	765	769	wild	wild	I-NP	JJ	B-protein	5	NMOD	B-protein
O	O	O	769	770	-	-	I-NP	HYPH	I-protein	5	NMOD	I-protein
O	O	O	770	774	type	type	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	775	777	or	or	O	CC	I-protein	12	NMOD	I-protein
O	O	O	778	785	mutated	mutate	B-VP	VBN	I-protein	12	NMOD	I-protein
O	O	O	786	791	human	human	B-NP	JJ	I-protein	12	NMOD	I-protein
T1	B-Protein	B-Protein	792	800	retinoic	retinoic	I-NP	JJ	I-protein	12	NMOD	I-protein
T1	I-Protein	I-Protein	801	805	acid	acid	I-NP	NN	I-protein	12	NMOD	I-protein
T1	I-Protein	I-Protein	806	814	receptor	receptor	I-NP	NN	I-protein	12	NMOD	I-protein
T1	I-Protein	I-Protein	815	820	alpha	alpha	I-NP	NN	I-protein	1	OBJ	I-protein
O	O	O	821	823	as	as	B-PP	IN	O	1	VMOD	O
O	O	O	824	825	a	a	B-NP	DT	O	15	NMOD	O
O	O	O	826	831	model	model	I-NP	NN	O	13	PMOD	O
O	O	O	831	832	,	,	O	,	O	28	P	O
O	O	O	833	836	kDa	kDa	B-NP	NN	O	18	NMOD	O
O	O	O	837	843	values	value	I-NP	NNS	O	28	SUB	O
O	O	O	844	854	determined	determine	B-VP	VBN	O	18	NMOD	O
O	O	O	855	857	by	by	B-PP	IN	O	19	VMOD	O
O	O	O	858	867	classical	classical	B-NP	JJ	O	24	NMOD	O
O	O	O	868	879	competition	competition	I-NP	NN	O	24	NMOD	O
O	O	O	880	887	binding	binding	I-NP	NN	O	24	NMOD	O
O	O	O	888	894	assays	assay	I-NP	NNS	O	20	PMOD	O
O	O	O	895	900	using	use	B-VP	VBG	O	24	NMOD	O
O	O	O	901	910	tritiated	tritiate	B-NP	VBN	O	27	NMOD	O
O	O	O	911	918	ligands	ligand	I-NP	NNS	O	25	OBJ	O
O	O	O	919	922	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	923	925	in	in	B-PP	IN	O	28	PRD	O
O	O	O	926	935	agreement	agreement	B-NP	NN	O	29	PMOD	O
O	O	O	936	940	with	with	B-PP	IN	O	30	NMOD	O
O	O	O	941	946	those	those	B-NP	DT	O	31	PMOD	O
O	O	O	947	955	measured	measure	B-VP	VBN	O	32	NMOD	O
O	O	O	956	958	by	by	B-PP	IN	O	33	VMOD	O
O	O	O	959	962	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	963	974	proteolytic	proteolytic	I-NP	JJ	O	37	NMOD	O
O	O	O	975	980	assay	assay	I-NP	NN	O	34	PMOD	O
O	O	O	980	981	.	.	O	.	O	28	P	O

O	O	O	982	986	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	987	993	method	method	I-NP	NN	O	3	SUB	O
O	O	O	994	997	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	998	1010	successfully	successfully	I-VP	RB	O	3	VMOD	O
O	O	O	1011	1019	extended	extend	I-VP	VBN	O	3	VC	O
O	O	O	1020	1022	to	to	B-PP	TO	O	5	VMOD	O
O	O	O	1023	1028	human	human	B-NP	JJ	B-protein	11	NMOD	B-protein
T2	B-Protein	B-Protein	1029	1037	retinoic	retinoic	I-NP	JJ	I-protein	11	NMOD	I-protein
T2	I-Protein	I-Protein	1038	1039	X	X	I-NP	NN	I-protein	11	NMOD	I-protein
T2	I-Protein	I-Protein	1040	1048	receptor	receptor	I-NP	NN	I-protein	11	NMOD	I-protein
T2	I-Protein	I-Protein	1049	1054	alpha	alpha	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	1054	1055	,	,	O	,	O	18	P	O
T3	B-Protein	B-Protein	1056	1070	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	14	NMOD	B-protein
T3	I-Protein	I-Protein	1071	1079	receptor	receptor	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	1079	1080	,	,	O	,	O	18	P	O
O	O	O	1081	1084	and	and	O	CC	O	18	NMOD	O
O	O	O	1085	1097	progesterone	progesterone	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	1098	1106	receptor	receptor	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	1106	1107	,	,	O	,	O	3	P	O
O	O	O	1108	1112	thus	thus	B-ADVP	RB	O	21	VMOD	O
O	O	O	1113	1122	providing	provide	B-VP	VBG	O	3	VMOD	O
O	O	O	1123	1124	a	a	B-NP	DT	O	23	NMOD	O
O	O	O	1125	1130	basis	basis	I-NP	NN	O	21	OBJ	O
O	O	O	1131	1134	for	for	B-PP	IN	O	23	NMOD	O
O	O	O	1135	1136	a	a	B-NP	DT	O	29	NMOD	O
O	O	O	1137	1140	new	new	I-NP	JJ	O	28	AMOD	O
O	O	O	1140	1141	,	,	I-NP	,	O	28	P	O
O	O	O	1142	1148	faster	fast	I-NP	JJR	O	29	NMOD	O
O	O	O	1149	1154	assay	assay	I-NP	NN	O	24	PMOD	O
O	O	O	1155	1157	to	to	B-VP	TO	O	31	VMOD	O
O	O	O	1158	1167	determine	determine	I-VP	VB	O	29	NMOD	O
O	O	O	1168	1182	simultaneously	simultaneously	B-ADVP	RB	O	31	VMOD	O
O	O	O	1183	1186	the	the	B-NP	DT	O	36	NMOD	O
O	O	O	1187	1195	affinity	affinity	I-NP	NN	O	36	NMOD	O
O	O	O	1196	1199	and	and	I-NP	CC	O	36	NMOD	O
O	O	O	1200	1212	conformation	conformation	I-NP	NN	O	31	OBJ	O
O	O	O	1213	1215	of	of	B-PP	IN	O	36	NMOD	O
O	O	O	1216	1225	receptors	receptor	B-NP	NNS	O	37	PMOD	O
O	O	O	1226	1230	when	when	B-ADVP	WRB	O	31	VMOD	O
O	O	O	1231	1236	bound	bind	B-VP	VBN	O	39	SBAR	O
O	O	O	1237	1239	to	to	B-PP	TO	O	40	VMOD	O
O	O	O	1240	1241	a	a	B-NP	DT	O	44	NMOD	O
O	O	O	1242	1247	given	give	I-NP	VBN	O	44	NMOD	O
O	O	O	1248	1254	ligand	ligand	I-NP	NN	O	41	PMOD	O
O	O	O	1254	1255	.	.	O	.	O	3	P	O
